Novo Nordisk Buys US Manufacturing Plant

By Dow Jones Business News, 
A A A


By Dominic Chopping

Danish insulin maker Novo Nordisk A/S (NOVO-B.KO) has bought a manufacturing facility in West Lebanon, New Hampshire, U.S. from Olympus Biotech, it said Wednesday.

Novo Nordisk said it intends to use the facility for production of active pharmaceutical ingredients primarily for its portfolio of biopharmaceuticals.

It added that some of the plant's former employees have been offered jobs, which will initially focus on planning of the future plant setup. Final plans will determine potential and timing for future staffing increases.

The companies have agreed not to disclose the terms of the acquisition.

-Write to Dominic Chopping at dominic.chopping@wsj.com; Twitter: @WSJNordics

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


  (END) Dow Jones Newswires
  08-27-140537ET
  Copyright (c) 2014 Dow Jones & Company, Inc.


This article appears in: News Headlines

Referenced Stocks: NOVC , NOVO-B , NOVOB , NVO

Dow Jones Business News


More from Dow Jones Business News:

Related Videos

Voya – Babies Retirement
Voya – Babies Retirement            

Stocks

Referenced

50%

Most Active by Volume

53,693,799
  • $8.39 ▲ 5.80%
49,425,856
  • $104.919 ▲ 1.87%
48,193,419
  • $12.11 ▼ 5.61%
41,664,329
  • $16.72 ▲ 1.95%
39,810,602
  • $33.5963 ▼ 2.62%
27,254,554
  • $98.32 ▲ 2.02%
24,436,354
  • $80.55 ▲ 2.78%
23,977,097
  • $45.385 ▲ 2.26%
As of 10/23/2014, 02:24 PM